Explore the evolving world of imaging cells in 3D
Jupiter, FL— In a new segment scheduled to be broadcasted in the 4th quarter 2018, Advancements with Ted Danson will educate audiences on recent advances in high-throughput cellular imaging. Check your local listings for more information.
This segment will focus on Molecular Devices innovative high content imaging platform which enable scientists to improve productivity and effectiveness of cell biology research, ultimately accelerating the discovery of new therapeutics.
With over 140,000 placements in laboratories around the world, Molecular Devices instruments have catalyzed brilliant scientific research described in over 150,000 peer reviewed publications. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection.
“We are proud to be in the forefront of the life science industry with leading-edge products in imaging, microplate detection, biotherapeutics, and analysis software,” said Greg Milosevich, President of Molecular Devices.
The company has over a 35-year history in innovation and quality and is over 1,100 associates strong with rich domain knowledge to support scientific breakthroughs.
“Molecular Devices is committed to the continual development of innovative solutions for life science applications,” said John Galvin, producer for the Advancements series. “We look forward to highlighting the technology and advancements taking place as a result of their research.”
About Molecular Devices:
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.
Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe.
For more information, visit: www.moleculardevices.com.
About Advancements and DMG Productions:
The Advancements series is an information-based educational show, targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.
Backed by experts in various fields, and a team dedicated to education and advancement, DMG Productions consistently produces commercial-free, educational programming on which both viewers and networks depend. For more info, please visit: AdvancementsTV.com.
